– Director of Brand Protection at Amgen, talks with GEN’s Editor-in-Chief John Sterling about Counterfeit Pharmaceuticals.

PodcastsResourcesBiopharmaceuticalsPharmacologyAMGen
Previous articleBiofirms Develop Novel Therapeutics for MS
Next articleDr. Stephan Schuster from Penn State University and Dr. William Farmerie from the University of Florida at Gainsville